Omalizumab-A review
Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE). The US FDA has approved this molecule for chronic urticaria.
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer Medknow Publications
2015-01-01
|
| Serie: | Indian Journal of Dermatology |
| Soggetti: | |
| Accesso online: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2015;volume=60;issue=4;spage=381;epage=384;aulast=Godse |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|